8-KRegulation FDExhibits & Filings

TransDigm Group INC 8-K Report, Regulation FD Disclosure (Apr 2, 2020)

Filed April 2, 2020For Securities:TDG

Summary

TransDigm Group Inc. (TDG) filed an 8-K on April 2, 2020, primarily to disclose information regarding a proposed offering of senior secured notes. The company also provided an update on the impact of the COVID-19 pandemic. Financially, the company highlighted its performance for the twelve-month period ended December 28, 2019, reporting net sales of $5,695 million and EBITDA As Defined of $2,613 million. Pro forma figures, which include the Esterline acquisition as if it occurred at the beginning of the period, showed an additional $286 million in net sales and $23 million in EBITDA As Defined. The company acknowledged the significant and evolving impact of the COVID-19 pandemic, particularly on its commercial aftermarket and OEM sales. In response, TransDigm plans to reduce its workforce by up to 15% and implement temporary furloughs. While designated an essential business, allowing operations to continue, the duration and severity of the pandemic's impact remain uncertain, with expectations of adverse effects on third-quarter results. The company is also reviewing potential benefits from the CARES Act.

Key Highlights

  • 1Proposed offering of senior secured notes by TransDigm Inc. to raise capital for general corporate purposes, including liquidity enhancement.
  • 2For the twelve months ended December 28, 2019, reported net sales of $5,695 million and EBITDA As Defined of $2,613 million.
  • 3Pro forma figures indicate the Esterline acquisition would have added approximately $286 million in net sales and $23 million in EBITDA As Defined for the twelve months ended December 28, 2019.
  • 4Acknowledged the significant and uncertain adverse impact of the COVID-19 pandemic on commercial aftermarket and OEM sales.
  • 5Announced workforce reduction of up to 15% and temporary furloughs due to the pandemic's expected impact on shipping levels.
  • 6Designated an essential business, allowing continued operations despite broader industry disruptions.
  • 7Currently examining the potential benefits of the CARES Act.
  • 8Anticipates a significant adverse impact on third-quarter fiscal 2020 sales, EBITDA As Defined, and net income.

Frequently Asked Questions